Treatment emergent peripheral neuropathy in the CASSIOPEIA trial

Cathelijne Fokkema; Phillipe Moreau; Bronno Van der Holt; Jérôme Lambert; Mark Van Duin; Ruth Wester; Joost L M Jongen; Pieter A Van Doorn; Sophie Godet; Kon Siong Jie; Olivier Fitoussi; Michel Delforge; Awa Keita-Manta; Odile Luycx; Tom Cupedo; Niels W C J Van de Donk; Sonja Zweegman; Jessica T Vermeulen; Pieter Sonneveld; Annemiek Broijl

doi:10.3324/haematol.2021.280567

Treatment emergent peripheral neuropathy in the CASSIOPEIA trial

Haematologica. 2022 Jul 1;107(7):1726-1730. doi: 10.3324/haematol.2021.280567.

Authors

Cathelijne Fokkema¹, Phillipe Moreau², Bronno Van der Holt³, Jérôme Lambert⁴, Mark Van Duin¹, Ruth Wester¹, Joost L M Jongen⁵, Pieter A Van Doorn⁵, Sophie Godet⁶, Kon Siong Jie⁷, Olivier Fitoussi⁸, Michel Delforge⁹, Awa Keita-Manta¹⁰, Odile Luycx¹¹, Tom Cupedo¹, Niels W C J Van de Donk¹², Sonja Zweegman¹², Jessica T Vermeulen¹³, Pieter Sonneveld¹, Annemiek Broijl¹⁴

Affiliations

¹ Department of Hematology, Erasmus MC Cancer Institute, Rotterdam.
² Hematology Department, University Hospital Hôtel-Dieu, Nantes.
³ HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam.
⁴ Biostatistical Department, Hospital Saint Louis, Paris.
⁵ Department of Neurology, Erasmus MC, Rotterdam.
⁶ Department of Hematology, University Hospital of Reims and UFR Médicine, Reims.
⁷ Department of Hematology, Zuyderland MC, Sittard.
⁸ Department of Hematology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux.
⁹ Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
¹⁰ Premier Research, CRO, Paris.
¹¹ Department of Hematology, Hospital Scorff Hospital Group Bretagne Sud, Lorient.
¹² Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam.
¹³ Janssen Research and Development, LLC, Leiden.
¹⁴ Department of Hematology, Erasmus MC Cancer Institute, Rotterdam. a.broyl@erasmusmc.nl.

No abstract available

Publication types

Clinical Trial, Phase III

MeSH terms

Aged
Bortezomib / therapeutic use
Female
Humans
Male
Middle Aged
Peripheral Nervous System Diseases* / diagnosis
Peripheral Nervous System Diseases* / etiology

Substances

Bortezomib

Grants and funding

Funding: This study was supported by Intergroupe Francophone du Myélome (IFM), the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) in collaboration with Janssen Research & Development and the Dutch Cancer Society (KWF).